S&P US 500

IVV

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

NASDAQ US 100

NDQ

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

Catapult Sports Ltd

CAT

Catapult Group International Ltd. engages in the development and supply of wearable athlete tracking and analytics solutions. The company is headquartered in Richmond, Victoria. The company went IPO on 2014-12-19. Its products are designed to optimize performance, avoid injury, and improve return to play. Its three main product verticals are: Performance & Health, Tactics & Coaching, and Media & Other. The Performance & Health is engaged in the design, development and supply of wearable technology and athlete monitoring software solutions to sports teams, athletes, and the prosumer market. Tactics & Coaching is engaged in the design, development and supply of video analysis, editing, and publishing software solutions to sports teams. Media & Other provides media licensing, athlete management and professional services to customers. The firm's solutions consist of athlete monitoring, video analysis, racing analysis, recruiting, and content licensing.

CSL

CSL

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 32,065 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.

Betashares Aus Top 20 Eqy Yield Max Complex ETF

YMAX

YMAX.AX was created on 2012-11-22 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. YMAX.AX aims to generate attractive quarterly income and reduce the volatility of portfolio returns by implementing an equity income investment strategy over a portfolio of the 20 largest blue-chip shares listed on the ASX. YMAX.AX does not aim to track an index.